Skip to main content

Month: September 2025

OHA is Administrative Agent & Lead Left Arranger of Private Unitranche Financing Supporting Francisco Partners’ Acquisition of Elite

New York, New York, Sept. 30, 2025 (GLOBE NEWSWIRE) — Oak Hill Advisors (“OHA”) served as Administrative Agent and Lead Left Arranger for a private unitranche financing supporting Francisco Partners’ acquisition of Elite. Elite is a leading provider of mission-critical enterprise resource planning (“ERP”) software and integrated payment solutions for law firms globally. OHA is the largest holder of the newly raised debt facility. This transaction follows OHA’s role as the sole lender for TPG’s carve-out of the company from Thomson Reuters in 2023. OHA’s familiarity with the company, combined with its decades of experience investing in ERP software companies, enabled a decisive and scaled financing solution. “Since our initial investment in Elite, the business has demonstrated a strong track record of performance and remarkable...

Continue reading

Opus Genetics Reports Positive Pediatric Data from OPGx-LCA5 Phase 1/2 Trial in Leber Congenital Amaurosis Type 5 (LCA5)

Pediatric participants demonstrated large gains in cone-mediated vision; therapy remains well tolerated with no ocular serious adverse events or dose-limiting toxicities Lasting, durable responses observed out to 18 months in adult participants Expected FDA Meeting in Q4 2025 Management to Host Webcast and Conference Call Today at 8:30 A.M. ETRESEARCH TRIANGLE PARK, N.C., Sept. 30, 2025 (GLOBE NEWSWIRE) — Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and small molecule therapies for other ophthalmic disorders, today announced positive three-month data from the pediatric cohort of its ongoing Phase 1/2 clinical trial (OPGx-LCA5-1001) evaluating OPGx-LCA5, an investigational gene augmentation therapy for Leber congenital...

Continue reading

Gogo Plane Simple Ka-band terminal certified for Dassault Falcon 7X and 8X aircraft

The Gogo Plane Simple Ka-band tail mount antenna system has received European Union Aviation Safety Agency (EASA) supplemental type certification (STC) approvals for Dassault Falcon 7X and 8X aircraftGogo Plane Simple Ka-band terminal certified for Dassault Falcon 7X and 8X aircraft.The high-performance solution allows multiple passengers using multiple devices to access video streaming, conferencing, email, voice calling, and multiple digital applications simultaneously.Broomfield, CO., Sept. 30, 2025 (GLOBE NEWSWIRE) — Gogo (NASDAQ: GOGO) announced today that the Gogo Plane Simple Ka-band tail mount antenna system has received European Union Aviation Safety Agency (EASA) supplemental type certification (STC) approvals for Dassault Falcon 7X and 8X aircraft. Gogo worked with Dassault Falcon Jet in Le Bourget, France,...

Continue reading

Lantronix Launches EdgeFabric.ai Visual Orchestration Platform to Accelerate Edge AI Deployment

Platform Empowers Customers to Bring AI From Prototype to Production in Minutes, Not Months IRVINE, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX), a global leader in compute and connectivity IoT solutions powering Edge AI applications, today unveiled EdgeFabric.ai™, a no-code development platform purpose-built exclusively for Lantronix Open-Q™ System-on-Module (SOM) solutions. With EdgeFabric.ai, businesses can design and deploy Edge AI applications in minutes, rather than months, without needing a team of AI experts. Targeted at high-growth markets such as smart surveillance, drones, transportation, traffic control, Industrial IoT, commercial infrastructure and defense/public safety, EdgeFabric.ai makes AI accessible to customers across widespread industries. Making Edge AI Simple Deploying...

Continue reading

Tilray, a Global Leader in Medical Cannabis, Announces Expansion of Premium Craft Cannabis Production at its Advanced EU-GMP Facility in Germany; Tilray Medical Enhances Tilray Craft Cannabis Portfolio with New Patient-Centered Offerings

NEUMÜNSTER, Germany, Sept. 30, 2025 (GLOBE NEWSWIRE) — Tilray Medical a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, transforming healthcare today announced the expansion of its Tilray Craft portfolio in Germany with five new cannabis flower products produced in Germany at Tilray’s EU‑GMP certified facility in Neumünster as part of the BfArM in‑country cultivation program. The additions reflect Tilray’s ongoing commitment to providing physicians and pharmacies with a diverse range of quality, EU‑GMP certified medical cannabis options for eligible patients. Rajnish Ohri, Managing Director International at Tilray Brands, commented, “The expansion...

Continue reading

Stella-Jones Expands its Utility Product Offering with an Agreement to Acquire Brooks Manufacturing Co.

Strategic acquisition adds complementary products to broaden market reach and accelerate growth MONTREAL, Sept. 30, 2025 (GLOBE NEWSWIRE) — Stella-Jones Inc. (TSX: SJ) (“Stella-Jones” or “the Company”) announced today that it has entered into a definitive agreement to acquire the assets of Brooks Manufacturing Co. (“Brooks”), a manufacturer of treated wood distribution crossarms and transmission framing components located in the United States. This transaction marks another significant step in the Company’s strategy to expand beyond its traditional product categories and leverage its extensive sales and distribution network to better support the needs of the utility sector. Founded in 1915, Brooks is a long-standing supplier to utilities with a proven track record of quality and customer service. It operates a facility located...

Continue reading

Draganfly Selected by U.S. Army to Supply Flex FPV Drone Systems

Tampa, Florida, Sept. 30, 2025 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an industry-leading developer of drone solutions and systems, today announced its selection by the U.S. Army to provide Flex FPV drone systems. Under the initial order, Draganfly will deliver Flex FPV drones designed for high-performance operations as well as help establish on-site manufacturing of the Flex FPV (First Person View) within overseas U.S. Forces facilities to accelerate deployment and reduce supply-chain timelines. The Company will also provide both flight and manufacturing training to enable Army personnel to sustain operations, and will manage logistics to ensure a secure, NDAA-compliant supply chain practice. This marks a significant milestone in evolving critical drone capabilities...

Continue reading

Ocular Therapeutix™ Announces Pricing of Underwritten Offering of Common Stock

BEDFORD, Mass., Sept. 30, 2025 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (Nasdaq: OCUL) (“Ocular”, the “Company”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced the pricing of an underwritten offering of 37,909,018 shares of its common stock at an offering price of $12.53 per share for gross proceeds of approximately $475.0 million, before deducting underwriting discounts and commissions and other offering expenses payable by the Company. All of the shares in the offering are to be sold by the Company. The offering is expected to close on or about October 1, 2025, subject to the satisfaction of customary closing conditions. BofA Securities, TD Cowen and Piper Sandler & Co. are acting as joint book-running managers for the offering. Baird and Raymond James are acting...

Continue reading

Qualigen Therapeutics Announces Successful Closing of $41 Million PIPE Financing Led by Faraday Future, Accelerating New Business Transformation into Crypto

Carlsbad, CA, Sept. 30, 2025 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (“Qualigen” or “the Company”) today announced the successful closing of a $41 million private investment in public equity (PIPE) financing led by Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“FF”), along with its Founder and Global Co-CEO YT Jia, President Jerry Wang, SIGN Foundation – a blockchain technology company backed by Binance Labs, Sequoia Capital (US, India, China), IDG, and Circle, and other leading investors. FF has invested $30 million in QLGN common and preferred stock, representing approximately 55% of pro forma beneficial ownership. YT Jia, has personally invested approximately $4 million and signed up a two-year voluntary lockup, representing approximately 7% ownership. The Company plans to use majority of the...

Continue reading

Gilat Receives Over $7 Million Orders to Supply Transportable SATCOM Terminals to the U.S. Army

Gilat Defense continues to supply WGS-certified DKET solution to strengthen mission-critical connectivity for U.S. defense operations PETAH TIKVA, Israel, Sept. 30, 2025 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announced today that Gilat DataPath has received orders of more than $7 million to provide additional Transportable SATCOM Terminals to the U.S. Army through a prime contractor. The orders include multiple units of the DKET 3421 transportable terminal along with associated support services, with deliveries scheduled for completion before the end of 2025. Gilat DataPath’s WGS-certified DKET 3421 is a combat-proven, rugged terminal designed to meet the most demanding mission requirements. Featuring multi-carrier...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.